# Molecular Partners (stock symbol: MOLN) Logo in transparent PNG and SVG formats

## Molecular Partners Logo large

### Molecular Partners Logo large Download PNG (37.83 KB)

![Molecular Partners Logo large Download PNG (37.83 KB)](/img/orig/MOLN_BIG-80746172.png)

### Molecular Partners Logo large Download SVG (7.06 KB)

![Molecular Partners Logo large Download SVG (7.06 KB)](/img/orig/MOLN_BIG-5ae8a623.svg)

## Molecular Partners Logo icon format

### Molecular Partners Logo icon format Download PNG (80.89 KB)

![Molecular Partners Logo icon format Download PNG (80.89 KB)](/img/orig/MOLN-1fc89582.png)

### Molecular Partners Logo icon format Download SVG (3.05 KB)

![Molecular Partners Logo icon format Download SVG (3.05 KB)](/img/orig/MOLN-35f85299.svg)

## About Molecular Partners

Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, as well as for diabetic macular edema; and MP0420, a multi-specific DARPin therapeutic candidate for the SARS-CoV-2 virus. The company develops MP0310, which is in Phase Ia clinical trials for immuno-oncology; MP0317, a tumor-localized immune agonist that activates immune cells in the tumor, which is in Phase I clinical trials; and MP0274 that is in Phase I clinical trials for HER2-positive cancers. It also develops MP0423 for treating COVID-19; MP0533, a CD3 T cell candidate for acute myeloid leukemia; and MP0250 for vascular endothelial growth factor, hepatocyte growth factor, and human serum albumin to increase half-life. Molecular Partners AG has agreements and collaboration with Novartis AG to develop, manufacture, and commercialize DARPin-conjugated radioligand therapies; Amgen SA; Allergan, Inc.; and discovery alliance with AbbVie Inc. in ophthalmology, as well as other third-party collaborators. The company was incorporated in 2004 and is headquartered in Schlieren, Switzerland.

1. Website domain: molecularpartners.com
2. Employees: 163
3. Marketcap: $0.23 Billion USD


## Categories
- [x] ðŸ‡¨ðŸ‡­ Switzerland
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
